According to recently published clinical research by Galderma in January 2025, patients using GLP-1 medications frequently report significant facial alterations: Loss of facial volume creating shadowing and hollowness Increased skin laxity and sagging Changes in facial structure and balance Skin appearing less radiant and drier An overall aged appearance beyond their chronological age Dr
We believe that weight loss is a clinical journey that deserves professional oversight without the barriers of traditional doctors offices
Free From: Gluten, soy, dairy, GMOs
However, because GLP-1 is being considered for long-term use, its essential to weigh the safety data carefully
The 32-week, multicentre, randomized, double-blind, active-controlled phase 2 trial aimed to evaluate the efficacy and safety of the combination therapy